Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: technetx who wrote (36)	3/17/1998 10:39:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Immucor Enters Agreement with IBG Systems NORCROSS, Ga., March 17 /PRNewswire/ -- Immucor, Inc. (Nasdaq: BLUD) maker of blood bank reagent systems and related products, announced today an agreement with IBG Systems Limited (IBG) headquartered in Shoreham-by-Sea, England. Founded in 1988 by Nick Stringer and Graham Smallridge, IBG Systems is a manufacturer and distributor of semi-automated blood grouping instrumentation in Europe and North America. Under the terms of the agreement, Immucor assumes the sales, marketing, service and support of all current and future IBG products in North America. IBG presently has the only semi-automated microtitration plate reader available for sale in the U.S to read and interpret Immucor's proprietary solid phase Capture(R) assays. With this agreement Immucor also obtains the IBG North American distribution rights to the Rosys Plato system manufactured by Rosys Anthos AG in Hombrechtikon, Switzerland. The Rosys Plato system is an automated liquid and sample handling pipetting system for processing microtitration plates used by clinical laboratories. Edward L. Gallup, President of Immucor, Inc. commented, "This agreement expands our corporate vision to become the world leader in blood bank automation by offering a line of automated and semi-automated products for all segments of the U.S. market. These products, along with our flagship product, the ABS2000 (Pending 510(k), not available for sale in the U.S.) and our high volume microtitration plate processing DIAS PLUS system, allow Immucor to offer instrumentation tailored to meet the needs of all clinical laboratory market segments." Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used primarily by hospitals, donor centers and large clinical laboratories in a number of tests performed to detect and identify certain properties of the cell and serum components of blood prior to transfusion. SOURCE Immucor, Inc. CO: Immucor, Inc.; IBG Systems Limited ST: Georgia IN: MTC SU: 03/17/98 10:20 EST prnewswire.com

To: technetx who wrote (36)	3/18/1998 12:35:00 PM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

ABS2000 Approval Confidence - High Technetx, Given my last post and the release of the recent news regarding IBG it is my opinion that ABS2000 approval is imminent. Immucor is fully aware of the 510(k) status for ABS2000 and has decided to act on that information by signing the agreement with IBG. Just my two cents. Regards, Tom

To: technetx who wrote (36)	7/8/1998 10:01:00 PM
From: Thomas Kirwin	Respond to of 422

Potential Immucor Suitors or Acquirers Competition There are other competitors with licenses to manufacture blood banking reagents in the United States. The Company's principal U.S. competitors for blood bank reagents are Ortho-Clinical Diagnostics, a Johnson & Johnson company, and Gamma Biologicals Inc. Additional European competitors for blood bank products include Biotest, a German company; and Diamed, a Swiss company. All of these companies have been established longer, some have larger market shares than the Company, and some have substantially greater financial and other resources than the Company. However, the Company believes that it is properly positioned to compete favorably in the business principally because of the quality and price of its products, the sale of innovative products such as the Company's Capture(registered trademark) products (see Products), continuing research efforts in the area of blood bank automation (see Products Under Development), the experience and expertise of its sales personnel (see Marketing and Distribution) and the expertise of its technical and customer support staff.